Molnupiravir Subject – Science and Tech Context – ‘Virus less likely to develop resistance to molnupiravir’ Concept – The anti-viral drug molnupiravir can reduce risk of hospitalisation or death by 50% in non-hospitalised adult patients with mild-to-moderate COVID-19 disease. That molnupiravir is an oral drug is a major advantage in treating patients as […]